These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


93 related items for PubMed ID: 8737752

  • 21. Placebo-controlled crossover comparison of spirapril at 3, 6, 12 and 24 mg once daily in mild to severe essential hypertension.
    Guitard C, Sassano P, Tzincoca C, Duchiez J, Safar ME.
    Blood Press Suppl; 1994; 2():61-8. PubMed ID: 8061848
    [Abstract] [Full Text] [Related]

  • 22. Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active-controlled, double-blind multicentre trial in patients with congestive heart failure.
    Widimský J, Kremer HJ, Jerie P, Uhlír O.
    Eur J Clin Pharmacol; 1995; 49(1-2):95-102. PubMed ID: 8751029
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Placebo effect and efficacy of nebivolol in patients with hypertension not controlled with lisinopril or losartan: a phase IV, randomized, placebo-controlled trial.
    Weiss RJ, Stapff M, Lin Y.
    Am J Cardiovasc Drugs; 2013 Apr; 13(2):129-40. PubMed ID: 23519546
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Angiotensin-converting enzyme inhibition with spirapril in patients with coronary artery disease.
    Thürmann P, Rietbrock N.
    Blood Press Suppl; 1994 Apr; 2():73-6. PubMed ID: 8061851
    [Abstract] [Full Text] [Related]

  • 29. Sustained-release isradipine compared with spirapril in the treatment of elderly patients with isolated systolic hypertension.
    Tomlinson B, Woo J, Critchley JA, Or KK, Chan TY, Sanderson JE.
    Am J Hypertens; 1994 Jul; 7(7 Pt 2):35S-39S. PubMed ID: 7946177
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Effects of acute and chronic angiotensin converting enzyme inhibition by spirapril on cardiovascular regulation in essential hypertensive patients. Assessment by spectral analysis and haemodynamic measurements.
    Veerman DP, Douma CE, Jacobs MC, Thien T, Van Montfrans GA.
    Br J Clin Pharmacol; 1996 Jan; 41(1):49-56. PubMed ID: 8824693
    [Abstract] [Full Text] [Related]

  • 33. Changes in left ventricular dimensions and haemodynamics during antihypertensive treatment with spirapril for 36 months.
    Otterstad JE, Froeland G.
    Blood Press Suppl; 1994 Jan; 2():69-72. PubMed ID: 8061849
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Randomized, double-blind comparison of irbesartan and enalapril for treatment of mild to moderate hypertension.
    Chiou KR, Chen CH, Ding PY, Chen YT, Ting CT, Huang JL, Chiang AH, Liu CP, Tseng CJ, Chao CT, Chang MS.
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):368-76. PubMed ID: 10862446
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
    Pelttari LH, Hietanen EK, Salo TT, Kataja MJ, Kantola IM.
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.